1-3 of 3
Hiroyuki Tsuda
Close
Sort by
Journal Articles

Prognostic Significance Of S-Phase Kinase-Associated Protein 2 (Skp2) In DLBCL Patients Treated With Upfront Autologous Peripheral Blood Stem Cell Transplantation

Takashi Okamura, MD, PhD, Ritsuko Seki, PhD, Koji Nagafuji, MD, PhD, Kisato Nosaka, MD, PhD, Takeshi Tsuchiya, MD, PhD, Hiroyuki Tsuda, M.D, PhD, Toshihiro Miyamoto, MD, Masakazu Higuchi, MD, PhD, Hitoshi Suzushima, MD, PhD, Michihiro Hidaka, MD, PhD, Abe Yasunobu, MD, PhD, Yuji Yufu, MD, PhD, Yutaka Imamura, MD, PhD, Masahiro Iwahashi, MD, PhD, Tomoaki Fujisaki, MD, PhD, Naokuni Uike, MD, PhD, Moriuchi Yukiyoshi, MD, PhD, Tetsuya Eto, MD, PhD, Gondo Hisashi, MD, PhD, Tomohiko Kamimura, MD PhD, Yasushi Takamatsu, MD, PhD, Ohshima Koichi, MD PhD
Journal: Blood
Blood (2013) 122 (21): 3022.
https://doi.org/10.1182/blood.V122.21.3022.3022
Published: 2013
Journal Articles

Regulation of p27 by S-Phase Kinase- Associated Protein 2 Is Associated with Aggressiveness in Diffuse Large B Cell Lymphoma (DLBCL)

Ritsuko Seki, Koichi Ohshima, Tomoaki Fujisaki, MD, Naokuni Uike, Fumio Kawano, Hisashi Gondo, Shigeyoshi Makino, Tetsuya Eto, MD, PhD, Yukiyoshi Moriuchi, Fumihiro Taguchi, Tomohiko Kamimura, M.D., Hiroyuki Tsuda, Ryosuke Ogawa, MD, PhD, Kazuya Shimoda, MD, PhD, Takashi Okamura, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3760.
https://doi.org/10.1182/blood.V112.11.3760.3760
Published: 2008
Journal Articles

High Skp2 Expression Is an Independent Predictor of Unfavorable Outcome in 333 Patients with Diffuse Large B Cell Lymphoma (DLBCL).

Ritsuko Seki, PhD, Koichi Ohshima, MD, Fumio Kawano, MD, Toshihiko Murayama, MD, Yukiyoshi Moriuchi, MD, Ryosuke Ogawa, MD, Kazuya Shimoda, MD, Hitoshi Suzushima, MD, Hiroyuki Tsuda, MD, Nobuyuki Arima, MD, Kunihiro Tsukazaki, MD, Keiko Suzuki, MD, Masahito Iwahashi, MD, Atae Utsunomiya, MD, Tadashi Matsumoto, MD, Takashi Okamura, MD
Journal: Blood
Blood (2007) 110 (11): 1560.
https://doi.org/10.1182/blood.V110.11.1560.1560
Published: 2007